Turkovac (pronunciation: Help:IPA/Turkish|) is a COVID-19 vaccine developed by Turkish Ministry of Health and Erciyes University. __TOC__ == Clinical trials == In November 2020, Turkovac started on phase I trials with 44 participants in Turkey.
via Wikipedia infobox
Turkovac (pronunciation: Help:IPA/Turkish|) is a COVID-19 vaccine developed by Turkish Ministry of Health and Erciyes University. __TOC__ == Clinical trials == In November 2020, Turkovac started on phase I trials with 44 participants in Turkey.
In February 2021, Turkovac started on phase II trials with 250 participants in Turkey.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).